Folate, homocysteine, endothelial function and cardiovascular disease. What is the link?

Area of Science:

• Cardiovascular Science
• Nutritional Biochemistry
• Vascular Physiology

Background:

• Elevated plasma homocysteine is linked to cardiovascular disease risk, though causality is unproven.
• Folate levels significantly influence homocysteine concentrations, interacting with methylenetetrahydrofolate reductase (MTHFR) gene variations.
• Endothelial dysfunction, characterized by reduced nitric oxide bioavailability, is an early indicator of vascular pathology.

Purpose of the Study:

• To review human studies on folic acid, homocysteine, and endothelial function.
• To investigate the potential independent effects of high-dose folic acid on endothelial function.
• To explore mechanisms beyond homocysteine reduction that might explain folic acid's vascular benefits.

Main Methods:

• Noninvasive assessment of endothelial function using flow-mediated dilatation (FMD).
• Review of existing human clinical studies examining folic acid supplementation.
• Analysis of studies correlating homocysteine levels, MTHFR genotype, and endothelial markers.

Main Results:

• Studies indicate a complex interplay between folate, homocysteine, and endothelial function.
• Evidence suggests high-dose folic acid may improve endothelial function.
• Observed benefits on endothelial function may occur independently of significant homocysteine lowering.

Conclusions:

• Folic acid, particularly in high doses, shows potential for improving endothelial function.
• The beneficial effects of folic acid on vascular health might extend beyond its homocysteine-lowering capacity.
• Further investigation is warranted to elucidate the precise mechanisms and clinical implications for cardiovascular disease prevention.